Skip to main content


Full Schedule

Full Schedule

  • Saturday, September 17, 2022
  • 7:15 AM – 8:15 AM CT
    Welcome Session: Healing: Our Path from Mental Illness to Mental Health
  • 8:30 AM – 9:45 AM CT
    Marijuana and Young People: A Combustible Combination
  • 8:30 AM – 9:45 AM CT
    Neurobiology and Pharmacology of Agitation and Irritability: Metadiagnostic Importance.
  • 8:30 AM – 9:45 AM CT
    State of Depression
  • 8:30 AM – 9:45 AM CT
    Telehealth Rules and Regulations: A Post-Pandemic Update
  • 8:30 AM – 9:45 AM CT
    The Muscarinic Cholinergic System's Role in Schizophrenia: Pathophysiology and Emerging Treatments
  • 10:00 AM – 11:15 AM CT
    DSM-5 Text Revision (DSM-5-TR): What’s New and What’s Different
  • 10:00 AM – 11:15 AM CT
    Managing ADHD and Comorbidities
  • 10:00 AM – 11:15 AM CT
    Measurement-Based Care in Depression and Beyond: What is it and how to make it work for your patients?
  • 10:00 AM – 11:15 AM CT
    Prevalence Of Autism Spectrum Disorder And Its Comorbid Conditions
  • 10:00 AM – 11:15 AM CT
    Taking a Team Approach to Parkinson Disease Psychosis: Evolving Strategies for Patients With or Without Dementia
  • 11:30 AM – 12:45 PM CT
    Addressing Persistent Myths and Misconceptions in Tardive Dyskinesia
  • 11:30 AM – 12:45 PM CT
    Pharmacotherapy for Anxiety Disorders: What is Available Currently and What is on the Horizon?
  • 11:30 AM – 12:45 PM CT
    Psychopharmacological Treatments for Anorexia Nervosa and Bulimia Nervosa and Future Areas of Research
  • 11:30 AM – 12:45 PM CT
    You’ve Asked Your Patient If They Are Thinking of Suicide and They Said ‘Yes’: What’s Next?
  • 1:00 PM – 2:15 PM CT
    Agitation Associated with Alzheimer’s Dementia (AAD): Clinical Presentation & Pathophysiology, Current Treatment & Unmet Need
  • 1:00 PM – 2:15 PM CT
    Beyond the Monoamine Hypothesis: A Glutamatergic Approach to Treating Major Depressive Disorder
  • 1:00 PM – 2:15 PM CT
    Coordination of Care Between Referring Psychiatrist and Treatment Center Provider
  • 1:00 PM – 2:15 PM CT
    IGALMI™ (dexmedetomidine) sublingual film • 120mcg, 180mcg • Now Approved
  • 1:00 PM – 2:15 PM CT
    TAAR1: Science Behind a Potential New TAARget for Schizophrenia
  • 1:00 PM – 2:15 PM CT
    Tardive Dyskinesia: Overcoming the Challenges of Differential Diagnosis & Treatment in the Era of Telepsychiatry
  • 2:30 PM – 3:45 PM CT
    Good Grief!: Prolonged Grief Disorder in the Context of COVID and Beyond
  • 2:30 PM – 3:45 PM CT
    Improving Shared Decision Making by Understanding Peer-Defined Treatment Outcomes
  • 2:30 PM – 3:45 PM CT
    Patient-Centered Management of Adult ADHD: Optimizing Long-Acting Stimulant Treatment
  • 2:30 PM – 3:45 PM CT
    When all else fails: New Developments in Neuromodulation for Resistant Depression
  • 4:00 PM – 5:15 PM CT
    Extensive Polypharmacy in Mood Disorders: Clever Combinations versus Clumsy Concoctions
  • 4:00 PM – 5:15 PM CT
    Impact of Trauma Across the Female Lifespan
  • 4:00 PM – 5:15 PM CT
    Long-Acting Injectable Antipsychotics: Newer Strategies for the Optimal Management of Bipolar I Disorder
  • 4:00 PM – 5:15 PM CT
    Using Antipsychotic Plasma Levels to Improve Measurement Based Care
  • 5:30 PM – 6:45 PM CT
    Managing Cognitive Complaints in Bipolar Disorder
  • 5:30 PM – 6:45 PM CT
    Nuances of Depression in High Functioning Women
  • 5:30 PM – 6:45 PM CT
    Patient Perspectives with Novel Dual Orexin Receptor Antagonists Use: Effective Treatment of Insomnia for Improved Outcomes in the Mental Health Community
  • 5:30 PM – 6:45 PM CT
    Resolving Ethical Dilemmas: How to Conduct an Ethical Analysis from Three Theoretical Perspectives
  • 7:00 PM – 8:45 PM CT
    Opening Night Reception In The Exhibit Hall
  • 7:30 PM – 8:30 PM CT
    Broadening Horizons: Artificial Intelligence and the Future of Digital Health in Psychiatry